Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJLF.L Regulatory News (JLF)

  • There is currently no data for JLF

Half Yearly Report

18 Jun 2009 07:00

RNS Number : 0358U
Jelf Group PLC
18 June 2009
Β 

ο»Ώ

18thΒ June 2008

Jelf Group plc

('Jelf' or 'Jelf Group' or 'The Group')

Interim Results for the six months ended 31 March 2009

JELF CONTINUED GROWTH

Jelf Group plc, a leading independent corporate consultancy providingΒ advice on insurance,Β employee benefits including healthcare, commercial finance and wealth management, today announces its interim results for the six months ended 31 March 2009.Β 

FINANCIAL HIGHLIGHTS

40% growth in Revenue to Β£35.0m (2008: Β£25.0m)

11% growth in EBITDAE to Β£3.5m (2008: Β£3.1m)

5% organic revenue growth in Employee BenefitsΒ 

Cash generated from operations of Β£8.3m (2008: Β£6.5m)Β 

10%Β EBITDAEΒ marginΒ (2008:Β 12%)

OPERATING HIGHLIGHTS

Growth continues,Β 

Good cross sales through existing client relationshipsΒ and major acquisitions

Integration of major acquisitions made in 2008 going to plan

Investment in people and systems continues

Focus on costs has achieved results but there is more to be doneΒ as the economic downturn continues

Award of 2* (Outstanding) Investors In Customers from (IIC)

Alex Alway, Group Chief Executive, said:

"Market conditions remain extremely difficultΒ and I do not expect that to change this year. Furthermore we have yet to see the benefits of a hardeningΒ ofΒ insuranceΒ rates in theΒ market.Β Β Despite these external factors,Β the overall growth in our revenues and profitsΒ highlights the resilience of the business. However, I do expect the economic downturn to continue into next year and this will present fresh challenges to both ourΒ clients and the Group which will have to be addressed."

Enquiries:

Jelf Group plcAlex Alway, Group Chief ExecutiveJohn Harding, Group Finance and Operations Director 01454 272 7130117 315 6563
Cenkos Securities plc Stephen KeysJulian Morse 020 7397 8926020 7397 1931

Notes to Editors:

Jelf Group was founded byΒ Chris JelfΒ in 1989. Today, the Jelf Group operates from a number of premises inΒ EnglandΒ &Β WalesΒ and offers an extensive range of corporate and private client services;

The Group advises in excess of 40,000 corporate clients across a range of disciplines. These clients cover the spectrum from significant public companies to small owner-managed businesses. Core Jelf clients are medium-sized owner-managed businesses.

The Group has continued to strengthen its corporate support infrastructure and integrate the acquisitions made.Β 

Further information is available on Jelf Group at the Group's website:Β www.jelfgroup.com.

Chairman's statement

Our strategy continues to be one of expanding the business through offering a broad range of services to new and existing clients. TheΒ range of services which we offer to owner-managed businesses, in particular, hasΒ enabledΒ the Group to maintain its resilience even within a challenging economic environment.

We continue to successfully integrate key acquisitions, and we are pleased with the performance of these businesses given the wider economic climate. TheΒ contribution of these acquisitions to ourΒ insurance and employee benefitsΒ businessesΒ continuesΒ to be in line with forecasts.Β 

Our organic growth (ex-acquisitions) has declined in the first half as a result of the economic downturn, which has affected all our businesses in varying degrees. We achieved positive organic growth in Employee Benefits and Commercial Finance, but Insurance and in particular Wealth Management experienced negative organic growth due to the difficult economic and investment climate. Our overall organic growth was negative (-6%), but remained largely flat excluding Wealth Management.

Given the economic climate, we haveΒ continued toΒ focus on reducingΒ ourΒ cost baseΒ andΒ improvingΒ operating efficiencies during this period; these efforts will continue.

Our operating cash flow remains strong, which has helped us to reduce our total debt (bank plus deferred consideration) in the first half from Β£49.3m to Β£42.3m (-Β£7.0m or -14%).

The results of the Group are biased to the key months of the third quarter of our financial year due to the start of the tax year in April, when a significant amount of business is conducted. The interim results reflect this bias.Β 

We would like to put on record our thanks for the continued support, dedication and professionalism of our staff. They continue to face considerable change within the business and constantly rise to the challenge.

I wouldΒ alsoΒ like to record our thanks to Bruce Carnegie-Brown,Β who retired from the Board in April 2009 following the acquisition ofΒ 3i QPE by the wider 3i Group.Β Bruce has made a valuable contribution to the Group in the last year, and we wish him well for the future.

TheΒ Board remains committed toΒ providing excellent service to our clients, and toΒ achievingΒ strong returnsΒ for our shareholders.

David Walker

Group Chairman

18th June 2009

Group Chief Executive's Statement

I amΒ pleased to beΒ in a position to report another set of solid results for the Group helped particularly by the successful integration of the three large acquisitions made last year. The economic climate is extremely challenging and the GroupΒ is takingΒ appropriate action to reduce its cost base to reflect thisΒ situation.Β 

We continue to make investments in people and infrastructure, to enable the business to execute our declared growth strategy.

Financial performance

In the six-month period ending 31 March 2009, the Group increased its turnover by 40% to Β£35.0m (2008: Β£25.0m);Β Operating profit has decreased from Β£1.6m to a loss of Β£0.4mΒ due to the impact of restructuring costs and increased amortisation;Β EBITDAE increased byΒ 11% to Β£3.5m (2008:Β Β£3.1m).

Underlying EBITDAE margin was downΒ 17% to 10% (2008: 12%).

Cash generated from operations was Β£8.3m. Performance-based deferred consideration payments on previous acquisitions amounted to Β£3.6m for the period. Our deferred consideration liabilities have beenΒ reduced during the period from Β£26.1m as at 30 September 2008 to an estimated Β£18.5m, due to payments and the impact of earn-out formulae.

Total bank debt, gross of capitalised loan fees,Β isΒ nowΒ Β£24.3m. This increased from Β£23.5m as at 30 September 2008, with additional borrowings being used to help fund the payment of the deferred consideration. This is in line with expectations.

Organisational development

We have selectively investedΒ in the Group's infrastructure in this period to enable integration whilst reducing back office costs. Infrastructure investment in technology and front-line support will always be a priority.

We have largely completed the process of migration of the core Healthcare business ontoΒ oneΒ system.Β 

Business Development

Insurance

Despite rating increasesΒ inΒ some elements of the market, the mid-to-large corporate market continues to be competitive due to a mixture of competition and the wider economic climate. The smaller owner-managed sector, where Jelf specialises, is less sensitive to incremental market rate movements and we have seen some rate increases here, but these have been offset by the difficultiesΒ faced byΒ many of our corporate clients and theΒ resultingΒ reduction of overall insurance covers. We anticipate that the challenging trading environment for our Insurance businesses will continue through 2009 and into the first half of 2010.

We have focused on reducing the cost base and theΒ integrationΒ of acquisitions during this period.

Despite these mixed market conditions, our client-focused approach has enabled us toΒ maintain strongΒ retentionΒ ratesΒ and to add value for clients.Β 

Employee Benefits

The market for advice onΒ EmployeeΒ Benefits remains resilient and the Group continues to enjoy a strong competitive position in this area. Clients continue to seek good advice, however theΒ conversion ofΒ pipeline prospects for corporate pensions is taking longer to materialise as the decision making process is slowed due to focus on other areas such as redundancies.Β 

TheΒ rates forΒ private medical insuranceΒ continueΒ toΒ hardenΒ and we are pleased to be able to reportΒ 13% organic growth on the previous year. The Group now places approximately Β£140m GWP annually in the private medical insurance market.

The results of the Healthcare business are weighted towards the second half of the financial year.Β 

During this period we have worked hard at getting closer to our Healthcare corporate clients to introduce the widerΒ suite ofΒ employee benefits services and products and this campaign is beginning to bolster the pipeline of future prospects.

Wealth Management

The market for independent advice to individuals has been extremely difficult in the current economic environment. Revenues have fallen byΒ justΒ 5%,Β due to the addition ofΒ the threeΒ acquisitions made last year, all of which hadΒ smallΒ elements of financial services business. AllΒ areas of adviceΒ areΒ down as client confidenceΒ in this marketΒ has ebbed.Β 

During this period we have reduced ourΒ cost base resulting in the release of a number of advisors and associated support staff. It is our intention to continue with the programme of integration and to focus on a smaller number of talented individuals whilst reducing costs further.Β 

The business assurance campaign launched in 2008 has provided significant organic sales into the Group's existing corporate clients that have underpinned these results. This will continue to be a primary focus throughout 2009.

The Group now has currently circa Β£270m (2008: Β£200m) in third-party funds on Wrap programmes producing fund-based income. Despite a strong inflow of funds, the overall amount under advice has reduced in line with equity price movements and remains market sensitive. In addition we continue to advise on over Β£1 billion of client funds under advice in old style product structures.

It is unlikely that we will see any return of confidence to this market during 2009Β and the first half of 2010.

Acquisitions

Whilst the Group has a healthy pipeline ofΒ potentialΒ acquisitions it has chosen not to invest during this period due to a lack of value. The consolidation of the intermediary market whilst slowing in pace has continued despite the wider economic difficulties.

The Insurance and Healthcare elements of the acquisitions made in 2008 are trading in line with expectations. These businesses did contain some Wealth Management businesses which although small in size are trading below expectations.Β 

People

I am particularly pleased at the progress made this year in the way the management and employees of the businesses acquired in 2008 have embraced the opportunities within the wider Group and are making a real contribution.

Whilst we have not made any acquisitions during this period and will have a strong focus onΒ operating efficiencies,Β we have continued to recruit and motivate key talent whilst strengthening the senior management team with appointments and promotions.

Our employees and management continue to deliver excellent value to our clients, shareholders and our strategic partners in the market. They remain our key asset.

Future

The Group will continue with its strategy of strengthening its position within its chosen sectors and providing a wider range of enhanced services to our clients.

The Jelf GroupΒ will continueΒ to place great emphasis onΒ superiorΒ customer serviceΒ to our clients .

Alex Alway

Group Chief Executive

18thΒ June 2009

ConsolidatedΒ Balance Sheet

Note

31 Mar 2009Β 

(unaudited)

31 MarΒ 2008Β 

(unaudited)

30 Sept 2008

Β (audited)

Β 

Β 

Β 

Β 

Β 

Β£'000

Β£'000

Β£'000

Non-current assets

Goodwill

69,786

46,086

73,972

Intangible assets

53,890

37,171

56,180

Property, plant and equipment

3,173

2,471

3,160

Available for sale investments

Β 

Β 

83

143

76

126,932

85,871

133,388

Current assets

Trade and other receivables

15,214

10,014

14,289

Cash and cash equivalentsΒ 1

24,791

32,538

21,832

Derivative financial instruments

Β 

Β 

-

61

-

40,005

42,613

36,121

Total assets

Β 

Β 

Β 

166,937

128,484

169,509

Current liabilities

Short-term provisions

(1,353)

(152)

(775)

Deferred income tax liability

(1,284)

(838)

(1,272)

Trade and other payables

(31,384)

(16,577)

(26,101)

Deferred consideration

(13,212)

(10,354)

(13,578)

Income tax liabilities

Β 

Β 

Β 

(2,515)

(972)

(2,670)

Derivative financial liabilities

(1,273)

-

(14)

Bank loans

Β 

Β 

Β 

(498)

-

(498)

(51,519)

(28,893)

(44,908)

Net currentΒ (liabilities)Β /Β assets

(11,514)

13,720

(8,787)

Non-current liabilities

Long-term provisions

(223)

(109)

(254)

Deferred income tax liability

(12,364)

(10,461)

(13,686)

Trade and other payables

(24)

(181)

(46)

Deferred consideration

(5,330)

(6,144)

(12,513)

Bank loans

(23,296)

(10,144)

(22,663)

(41,237)

(27,039)

(49,162)

Total liabilities

Β 

Β 

Β 

(92,756)

(55,932)

(94,070)

Net assets

Β 

Β 

Β 

Β 

74,181

72,552

75,439

Equity

Share capital

5,6

498

498

498

Share premium

6

54,850

54,875

54,850

Merger reserve

10,742

10,742

10,742

Other reserves

6

448

(387)

712

Retained earnings

6

7,643

6,824

8,637

Total equity

Β 

Β 

Β 

74,181

72,552

75,439

1 Included within cash and cash equivalents is fiduciary cash of Β£18,951,000Β (31 March 2008: Β£12,837,000; 30 September 2008: Β£18,161,000).

The notes on pagesΒ 10Β toΒ 14Β form an integral part of theseΒ condensed interim financial statements.

Consolidated income statement

Note

Six months endedΒ 

31 Mar 2009

(unaudited)

Six months endedΒ 

31 Mar 200

Β (unaudited)

YearΒ  endedΒ 

30 Sept 2008Β 

(audited)

Β 

Β 

Β 

Β 

Β 

Β 

Β£'000

Β£'000

Β£'000

Revenue

35,019

25,024

63,147

Cost of Sales

Β 

Β 

Β 

Β 

(2,195)

(2,036)

(4,758)

Gross Profit

32,824

22,988

58,389

Administrative expenses

Β 

Β 

Β 

(33,253)

(21,399)

(53,308)

OperatingΒ (loss) /Β profit

(429)

1,589

5,081

OperatingΒ (loss) /Β profit consists of:

Earnings before interest, taxation, depreciation,Β 

amortisationΒ andΒ exceptional (EBITDAE)

3,450

3,110

10,066

Group reorganisation and rationalisation costs

8

(1,099)

-

(666)

Depreciation ofΒ property, plant and equipment

(432)

(317)

(738)

Amortisation of intangibleΒ assets

Β 

Β 

(2,348)

(1,204)

(3,581)

Investment revenues

30

153

308

Finance costs

Β 

Β 

Β 

Β 

(965)

(1,004)

(1,875)

(Loss) / Profit before income tax

(1,364)

738

3,514

Income taxΒ credit / (expense)

Β 

Β 

Β 

370

(118)

(1,081)

Β (Loss) / profit for the period

Β 

Β 

(994)

620

2,433

Β 

Β 

Β 

Β 

Β 

Β 

(Loss) /Β earnings per shareΒ attributable to equity holders of the Company

Basic (pence)

4

(2.0)

2.0

6.1

Diluted (pence)

Β 

Β 

Β 

4

(2.0)

1.9

6.0

All results are derived from continuing operationsΒ 

Consolidated statement of recognised income and expense

Six monthsΒ 

endedΒ 

31 Mar 2009Β 

(unaudited)

Six months endedΒ 

31 MarΒ 2008 (unaudited)

YearΒ  endedΒ 

30 Sept 2008Β 

(audited)

Β 

Β 

Β 

Β 

Β 

Β 

Β£'000

Β£'000

Β£'000

(Loss) / gain on cash flow hedgesΒ (net of tax)

Β 

Β 

(903)

61

(14)

Net (loss) / income recognised directly in equity

(903)

61

(14)

(Loss) / profit for the period

(994)

620

2,433

Total recognised income and expense for the period

(1,897)

681

2,419

Consolidated cash flow statement

Note

Six months endedΒ  31 Mar 2009 (unaudited)

Six months endedΒ  31 Mar 2008(restated andΒ unaudited)

YearΒ  endedΒ  30 Sept 2008(audited)

Β 

Β 

Β 

Β 

Β£'000

Β£'000

Β£'000

Cash flows from operating activities

Cash generated from operations

7

8,345

6,471

10,538

Interest paid

(1,003)

(872)

(1,642)

Taxation paid

(778)

(3,146)

(2,817)

Net cashΒ flowΒ from operating activities

Β 

Β 

6,564

2,453

6,079

Cash flows from investing activities

Interest received

29

193

276

Proceeds on disposal of property, plant and equipment

14

-

-

Purchase of property, plant and equipment

(458)

(467)

(892)

Purchase of intangible assets

(57)

(174)

(279)

Purchase of own shares

(91)

(695)

(725)

Acquisition of subsidiaries and businessesΒ 1

25

(12,135)

(35,354)

Deferred consideration paidΒ 2

(3,609)

(985)

(4,724)

Net cashΒ flowΒ used in investing activities

Β 

Β 

(4,147)

(14,263)

(41,698)

Cash flows from financing activities

Repayments of bank loans

-

(23,870)

(23,870)

Repayments of obligations under finance leases

(31)

-

(43)

Proceeds on issue of shares (net of expenses)

-

44,994

44,994

AdditionalΒ bank loans raised (net of expenses)

Β 

Β 

573

13,954

27,100

Net cash flow from financing activities

Β 

Β 

542

35,078

48,181

Net increase in cash and cash equivalents

2,959

23,268

12,562

Cash and cash equivalents at beginning of period

21,832

9,270

9,270

Cash and cash equivalents at end of periodΒ 3

Β 

24,791

32,538

21,832

1 Cash inflow fromΒ theΒ acquisition of subsidiaries and businesses for the six months ended 31 Mar 2009 has been shown net of Β£63,000Β receiptΒ relating to a net asset settlement on a previous acquisition. 2 The condensed interim financial statements for the six months ended 31 March 2008 disclosed deferred consideration paid asΒ a financing activity. This has subsequently been restated to be an investing activity.3 Included within cash and cash equivalents is fiduciary cash of Β£18,951,000Β (31 March 2008: Β£12,837,000; 30 September 2008: Β£18,161,000).

1. General information

Jelf Group plc is an AIM listedΒ company incorporated in theΒ United KingdomΒ under the Companies Act 1985. The address of the registeredΒ office is given in noteΒ 9.

These condensed interim financial statements do not comprise statutory accounts under the meaning of Section 240 of the Companies Act 1985Β andΒ should be read in conjunction with the statutory accounts for the year ended 30Β SeptemberΒ 2008. These wereΒ prepared underΒ International Financial Reporting Standards (IFRSs),Β whichΒ were approved by the Board of Directors onΒ 2 February 2009Β and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 237 (2) or (3) of the Companies Act 1985.

These financial statements are presented in pounds sterling because that is the currency of the primary economic environment in which the Group operates.

2. Basis of preparation

The condensed financial statements have been prepared using accounting policies consistent withΒ IFRSsΒ as adopted for use in the European UnionΒ and the AIM rulesΒ and as disclosed in the Group's statutory accounts for the year ended 30 September 2008. These condensed financial statements do not comply with all the requirements of IAS 34 'Interim financial reporting' as the Company is not required to adopt this.

The statutory accounts for the year ended 30 September 2008 were the Group's first under IFRS and the reserves at 1 October 2007 have been restated accordingly.

The Group has applied s131 of the Companies Act 1985 in respect of merger relief. An adjustment in respect of this has been made to the equity reserves at 31 March 2008 and the relevant balances restated.

3. Segmental Reporting

TheΒ Board have determined that theΒ Group hasΒ five business sectors: Insurance, Healthcare, EmployeeΒ Benefits,Β CommercialΒ Finance andΒ WealthΒ Management. Business sector data includes an allocation of corporate costs toΒ eachΒ sector. There are no sales between business sectors.

All turnover arose within theΒ United Kingdom. No secondary segment information is therefore given. SegmentΒ informationΒ about these businesses is presented below.

Six monthsΒ 

endedΒ  31 Mar 2009

(unaudited)

Six monthsΒ 

endedΒ  31 Mar 2008

(unaudited)

Year endedΒ  30 Sept 2008

Β (audited)

Β 

Β 

Β£'000

Β£'000

Β£'000

Revenue

Insurance

22,641

13,824Β 

35,852

Healthcare

4,905

3,664Β 

9,796

Employee benefits

3,112

3,024Β 

7,842

Commercial finance

317

268Β 

627

Wealth management

4,044

4,244Β 

9,030

Β 

Β 

35,019

25,024Β 

63,147

Six months endedΒ  31 Mar 2009

(unaudited)

Six monthsΒ 

endedΒ  31 Mar 2008

(unaudited)

Year endedΒ  30 Sept 2008

(audited)

Β 

Β 

Β£'000

Β£'000

Β£'000

(Loss) /Β profitΒ for the period

Insurance

3,479

2,506Β 

6,173

Healthcare

814

181Β 

2,382

Employee benefits

(319)

152Β 

961

Commercial finance

(111)

(47)

2

Wealth management

Β 

(413)

318Β 

548

Earnings before interest, taxation, depreciation, amortisation andΒ exceptional (EBITDAE)

3,450

3,110Β 

10,066

Group reorganisation and rationalisation costs

(1,099)

-

(666)

Depreciation of tangible fixed assets

(432)

(317)

(738)

Amortisation of intangible fixed assets

(2,348)

(1,204)

(3,581)

Investment revenues

30

153Β 

308

Finance costs

(965)

(1,004)

(1,875)

Income taxΒ credit / (expense)

370

(118)

(1,081)

(Loss) / profit for the period

(994)

620

2,433

Balance sheet

TotalΒ assets

Insurance

114,890

61,559

118,906

Healthcare

28,185

25,999

25,595

Employee benefits

4,304

7,671

6,781

Commercial finance

694

181

661

Wealth management

15,236

15,060

15,843

Unallocated

3,628

18,014

1,723

166,937

128,484

169,509

TotalΒ liabilities

Insurance

(65,437)

(32,004)

(58,102)

Healthcare

(23,438)

(12,976)

(22,404)

Employee benefits

(1,371)

(3,476)

(3,253)

Commercial finance

(94)

(532)

(3,021)

Wealth management

(2,416)

(6,944)

(7,290)

(92,756)

(55,932)Β 

(94,070)

Other information

Capital additions

Insurance

107

67

517

Healthcare

7

154

161

Employee benefits

186

108

79

Commercial finance

-

-

14

Wealth management

237

204

132

Β 

Β 

537

533

903

Six monthsΒ 

endedΒ  31 Mar 2009Β 

(unaudited)

Six monthsΒ 

endedΒ  31 Mar 2008

(unaudited)

YearΒ 

endedΒ  30 Sept 2008 (audited)

Β 

Β 

Β£'000

Β£'000

Β£'000

Other information

Depreciation

Insurance

196

143

380

Healthcare

36

36

75

Employee benefits

84

47

101

Commercial finance

2

3

4

Wealth management

114

88

178

Β 

Β 

432

317

738

Amortisation

Insurance

1,753

829

2,677

Healthcare

356

271

517

Employee benefits

54

6

75

Commercial finance

-

-

1

Wealth management

185

98

311

Β 

Β 

2,348

1,204

3,581

4. (Loss) / earnings per share

(Loss) / earnings per share attributable to the equity holders of the Company are as follows:-

Six months endedΒ  31 Mar 2009

(unaudited)

Six monthsΒ 

endedΒ  31 Mar 2008Β 

(unaudited)

YearΒ endedΒ  30 Sept 2008Β (audited)

(Loss) /Β profit for the period (Β£'000)

(994)

620

2,433

AmortisationΒ and exceptionalsΒ (net of tax) (Β£'000)

2,212

1,204

3,088

Underlying profit for the period (Β£'000)1

1,218

1,824

5,521

Weighted average shares in issueΒ 

(number)

Basic

49,099,240

30,580,433

39,608,301

Β 

Diluted

Β 

49,341,872

32,688,794

40,385,502

(Loss) / earnings per shareΒ 

(pence)

Basic

(2.0)

2.0

6.1

Β 

Diluted2

(2.0)

1.9

6.0

Amortisation and exceptional per shareΒ 

(pence)

Basic

4.5

4.0

7.8

DilutedΒ 

4.5

3.7

7.6

Underlying earnings per share1

(pence)

BasicΒ 

2.5

6.0

13.9

Β 

DilutedΒ 

2.5

5.6

13.7

1. before deduction of amortisation of intangible fixed assetsΒ andΒ exceptional

2. in accordance with IAS33 Earnings per Share, the basic weighted average shares in issue has been used toΒ calculate theΒ  2009 loss per share due to the antidilutive nature of losses

5. Share capital

As at 31 March 2009Β the Company had authorised share capital of 100,000,000 (31 March and 30 September 2008: 100,000,000) ordinary shares of 1p each, of whichΒ 49,802,687Β (31 March 2008:Β 49,787,906, 30 September 2008:Β 49,802,687) ordinary shares have been allotted, called up and fully paid.

At 31 March 2009, of the called up share capital,Β 780,968Β (31 March 2008:Β 423,809, 30 September 2008:Β 785,609) ordinary shares were held by the Jelf Group plc Employee Benefit Trust and are shown within other reserves.

On 25 February 2008 22,117,648 new ordinary shares of 1p each were issued for Β£45.0m, net of share issue costs, and admitted to AIM. The new ordinary shares will rank pari passu with the existing ordinary shares of the Company.

6. Statement of changesΒ in equity

ShareΒ  capital

ShareΒ  premium

Merger reserve

HedgingΒ  reserve1,2

Share

based payment reserve1

Own shares held1

Other reserves1

Profit and loss account

Total

Equity

Β 

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

At 1 October 2007 (restatedΒ and audited)

257Β 

10,103

6,144

-Β 

757Β 

(851)

14

6,204Β 

22,628

Share based payments

-

-

-

-

327Β 

-

-

327

Share issue (net of issue costs)

241Β 

44,772

4,598

-

-

-

-

-

49,611

Purchase of own shares by EBT

-

-

-

-

-

(695)

-

-

(695)

Unrealised gain on cash flow hedges

-

-

-

61Β 

-

-

-

-

61

Profit for the period

-

-

-

-

-

-

-

620

620

At 31 March 2008 (unaudited)

498Β 

54,875

10,742

61Β 

1,084Β 

(1,546)

14

6,824

72,552

Share based payments

-

-

-

-

1,204

-

-

-

1,204

Share issue costs

-

(25)

-

-

-

-

-

-

(25)Β 

Purchase of own shares by EBT

-

-

-

-

-

(30)

-

-

(30)

Unrealised loss on cash flow hedges

-

-

-

(75)

-

-

-

-

(75)

Profit for the period

-

-

-

-

-

-

-

1,813

1,813

At 30 September 2008Β (audited)

498

54,850

10,742

(14)

2,288

(1,576)

14

8,637

75,439

Share based payments

-

-

-

-

730

-

-

-

730

Purchase of own shares by EBT

-

-

-

-

-

(91)

-

-

(91)

Unrealised lossΒ on cash flow hedges

-

-

-

(903)

-

-

-

-

(903)

LossΒ for the period

-

-

-

-

-

-

-

(994)

(994)

At 31 March 2009 (unaudited)

498

54,850

10,742

(917)

3,018

(1,667)

14

7,643

74,181

1 shown within other reserves on the balance sheet

2 shown net of tax

7. Cash generated from operations

Six monthsΒ 

endedΒ  31 Mar 2009

(unaudited)

Six months endedΒ  31 Mar 2008

(unaudited)

YearΒ endedΒ  30 Sept 2008

(audited)

Β 

Β 

Β 

Β£'000

Β£'000

Β£'000

(Loss) / profit for the period

(994)

620

2,433

Adjustments for:

Investment revenues

(30)

Β (153)

(308)

Finance costs

965

1,004Β 

1,875

Income taxΒ (credit) / expense

(370)

118Β 

1,081

Depreciation of property, plant and equipment

432

317

738

Amortisation of intangible assets

2,348

1,204Β 

3,581

Share-based payment expense

730

327Β 

1,069

Capitalised share-based payments

-

-

461

Increase in provisions

547

12

862

Operating cash flows before movement

in working capital

3,628

3,449

11,792

Increase in receivables

(992)

(6,641)

(172)

IncreaseΒ / (decrease)Β in payables

5,709

9,663

(1,082)

Cash generatedΒ fromΒ operations

Β 

8,345

6,471Β 

10,538

8. Exceptional costs

Β£1,099,000 (31 March 2008: Β£nil, 30 September 2008: Β£666,000) of Group reorganisation and rationalisation costs are a result of combining and restructuring operations. These costs are not associated with the ongoing activities of the Group.

9. Copies of the Interim Financial Statements

Copies ofΒ this Interim Report and AccountsΒ announcementΒ are available on the Group's websiteΒ (www.jelfgroup.com) or from the Company Secretary at the Company's registered office: Fromeforde House,Β Church Road, Yate,Β Bristol,Β BS37 5JB.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR CKOKPCBKKBAD
Date   Source Headline
1st Dec 20159:58 amRNSScheme effective
25th Nov 201512:20 pmRNSCourt sanction of Scheme of Arrangement
25th Nov 20157:30 amRNSSuspension - Jelf Group plc
24th Nov 20153:29 pmRNSForm 8.3 - [Jelf Group Plc]
24th Nov 201511:37 amBUSForm 8.3 - Jelf Group Plc
24th Nov 20157:00 amRNSSuspension of Trading of Shares
20th Nov 20154:01 pmRNSForm 8.3 - [Jelf Group Plc]
20th Nov 201511:28 amRNSForm 8.3 - [Jelf Group Plc]
20th Nov 201510:48 amBUSForm 8.3 - Jelf Group Plc
19th Nov 20153:29 pmRNSForm 8.3 - [Jelf Group Plc]
18th Nov 20152:48 pmRNSForm 8.3 - [Jelf Group plc]
18th Nov 201512:03 pmBUSForm 8.3 - Jelf Group Plc
17th Nov 20155:01 pmRNSUpdate to timetable of principal events
17th Nov 201511:45 amBUSForm 8.3 - Jelf Group Plc
16th Nov 20154:17 pmRNSUpdate on Acquisition
16th Nov 201511:53 amBUSForm 8.3 - Jelf Group Plc
13th Nov 201511:54 amBUSForm 8.3 - Jelf Group Plc
10th Nov 201511:49 amBUSForm 8.3 - Jelf Group Plc
9th Nov 20153:30 pmRNSForm 8.3 - Jelf Group Plc
9th Nov 20153:29 pmRNSForm 8.3 - [Jelf Group Plc]
9th Nov 20151:14 pmRNSForm 8.3 - Jelf Group PLC
9th Nov 201511:47 amBUSForm 8.3 - Jelf Group Plc
6th Nov 20153:30 pmRNSForm 8.3 - Jelf Group Plc
6th Nov 201511:46 amBUSForm 8.3 - Jelf Group Plc
4th Nov 20153:30 pmRNSForm 8.3 - Jelf Group Plc
4th Nov 201511:57 amBUSForm 8.3 - Jelf Group Plc
30th Oct 201512:01 pmBUSForm 8.3 - Jelf Group Plc
30th Oct 201510:38 amRNSForm 8.3 - JELF GROUP PLC
29th Oct 20153:31 pmRNSResults of Court and General Meetings
29th Oct 201511:24 amBUSForm 8.3 - Jelf Group Plc
29th Oct 20158:48 amRNSForm 8.3 - JELF GROUP PLC
28th Oct 201510:56 amBUSForm 8.3 - Jelf Group Plc
28th Oct 20159:38 amRNSForm 8.3 - JELF GROUP PLC
27th Oct 201511:11 amBUSForm 8.3 - Jelf Group Plc
27th Oct 20159:47 amRNSForm 8.3 - JELF GROUP PLC
26th Oct 20152:48 pmRNSForm 8.3 - [Jelf Group Plc]
26th Oct 201511:54 amBUSForm 8.3 - Jelf Group Plc
26th Oct 20159:50 amRNSForm 8.3 - JELF GROUP PLC
23rd Oct 20158:24 amRNSForm 8.3 - Jelf Group PLC
22nd Oct 201511:42 amBUSForm 8.3 - Jelf Group Plc
21st Oct 201512:00 pmRNSForm 8.5 (EPT/RI)
21st Oct 201511:11 amBUSForm 8.3 - Jelf Group Plc
21st Oct 201511:05 amRNSForm 8.3 - [Jelf Group Plc]
20th Oct 201511:45 amBUSForm 8.3 - Jelf Group Plc
20th Oct 20158:43 amRNSForm 8.3 - Jelf Group PLC
19th Oct 201512:09 pmBUSForm 8.3 - Jelf Group Plc
19th Oct 20158:19 amRNSForm 8.3 - Jelf Group PLC
16th Oct 201510:53 amBUSForm 8.3 - Jelf Group Plc
16th Oct 20159:24 amRNSForm 8.3 - JELF GROUP PLC
15th Oct 201511:09 amBUSForm 8.3 - JELF GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.